Cargando…
REG4 is a Potential Biomarker for Radiochemotherapy Sensitivity in Colorectal Cancer
PURPOSE: Colorectal cancer (CRC) is one of the most common types of malignancies, and radiochemotherapy (RCT) followed by surgery is the recommended approach for CRC treatment. However, some cases do not respond to first-line conventional chemotherapy or even progress further after treatment. Moreov...
Autores principales: | Gao, Lei, Wu, Xingjun, Zhang, Libo, Dai, Yang, Zhu, Zhe, Zhi, Yunqing, Wang, Kaijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936684/ https://www.ncbi.nlm.nih.gov/pubmed/33688207 http://dx.doi.org/10.2147/OTT.S296031 |
Ejemplares similares
-
Expression of VEGF and HIF-1α in locally advanced cervical cancer: potential biomarkers for predicting preoperative radiochemotherapy sensitivity and prognosis
por: Zhu, Pengfeng, et al.
Publicado: (2016) -
The Clinical Significance and Mechanisms of REG4 in Human Cancers
por: Zhang, Junyan, et al.
Publicado: (2021) -
Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2021) -
Radiochemotherapy
Publicado: (1998) -
The role of Reg IV in colorectal cancer, as a potential therapeutic target
por: Hu, Yiwang, et al.
Publicado: (2015)